Structure

Physi-Chem Properties

Molecular Weight:  612.17
Volume:  554.954
LogP:  -0.336
LogD:  -0.343
LogS:  -3.238
# Rotatable Bonds:  8
TPSA:  247.43
# H-Bond Aceptor:  16
# H-Bond Donor:  8
# Rings:  5
# Heavy Atoms:  16

MedChem Properties

QED Drug-Likeness Score:  0.124
Synthetic Accessibility Score:  4.7
Fsp3:  0.519
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.434
MDCK Permeability:  4.921112849842757e-05
Pgp-inhibitor:  0.002
Pgp-substrate:  0.996
Human Intestinal Absorption (HIA):  0.91
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.995

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.142
Plasma Protein Binding (PPB):  66.9910659790039%
Volume Distribution (VD):  0.678
Pgp-substrate:  21.49875831604004%

ADMET: Metabolism

CYP1A2-inhibitor:  0.027
CYP1A2-substrate:  0.602
CYP2C19-inhibitor:  0.017
CYP2C19-substrate:  0.264
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.113
CYP2D6-inhibitor:  0.01
CYP2D6-substrate:  0.175
CYP3A4-inhibitor:  0.007
CYP3A4-substrate:  0.008

ADMET: Excretion

Clearance (CL):  1.396
Half-life (T1/2):  0.709

ADMET: Toxicity

hERG Blockers:  0.238
Human Hepatotoxicity (H-HT):  0.139
Drug-inuced Liver Injury (DILI):  0.974
AMES Toxicity:  0.785
Rat Oral Acute Toxicity:  0.012
Maximum Recommended Daily Dose:  0.002
Skin Sensitization:  0.159
Carcinogencity:  0.207
Eye Corrosion:  0.003
Eye Irritation:  0.025
Respiratory Toxicity:  0.015

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC102028

Natural Product ID:  NPC102028
Common Name*:   1-O-[Beta-D-Glucopyranosyl-(1->6)-Beta-D-Glucopyranosyl]-8-Hydroxy-3,5-Dimethoxyxanthone
IUPAC Name:   8-hydroxy-3,5-dimethoxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyxanthen-9-one
Synonyms:  
Standard InCHIKey:  AHBKLQCFFXMAJT-YUMVGKRXSA-N
Standard InCHI:  InChI=1S/C27H32O16/c1-37-9-5-12-17(20(32)16-10(29)3-4-11(38-2)25(16)40-12)13(6-9)41-27-24(36)22(34)19(31)15(43-27)8-39-26-23(35)21(33)18(30)14(7-28)42-26/h3-6,14-15,18-19,21-24,26-31,33-36H,7-8H2,1-2H3/t14-,15-,18-,19-,21+,22+,23-,24-,26-,27-/m1/s1
SMILES:  OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(OC)cc4c3c(=O)c3c(o4)c(OC)ccc3O)[C@@H]([C@H]([C@@H]2O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2409394
PubChem CID:   71745144
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9824 Swertia kouitchensis Species Gentianaceae Eukaryota n.a. n.a. n.a. PMID[23805995]
NPO9824 Swertia kouitchensis Species Gentianaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO9824 Swertia kouitchensis Species Gentianaceae Eukaryota n.a. n.a. n.a. Database[TCMID]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 = 693000.0 nM PMID[456542]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC102028 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9877 High Similarity NPC156977
0.9877 High Similarity NPC267254
0.9877 High Similarity NPC142996
0.9816 High Similarity NPC51774
0.9816 High Similarity NPC239549
0.9816 High Similarity NPC236191
0.9815 High Similarity NPC52353
0.9815 High Similarity NPC293004
0.9815 High Similarity NPC194483
0.9755 High Similarity NPC301683
0.9753 High Similarity NPC293629
0.9753 High Similarity NPC472383
0.9753 High Similarity NPC472381
0.9695 High Similarity NPC204693
0.9693 High Similarity NPC79056
0.9693 High Similarity NPC22195
0.9693 High Similarity NPC105095
0.9693 High Similarity NPC44328
0.9693 High Similarity NPC183357
0.9693 High Similarity NPC44558
0.9693 High Similarity NPC21190
0.9693 High Similarity NPC177731
0.9691 High Similarity NPC93099
0.9639 High Similarity NPC475261
0.9634 High Similarity NPC3583
0.9634 High Similarity NPC259152
0.9634 High Similarity NPC472386
0.9634 High Similarity NPC475155
0.9632 High Similarity NPC210042
0.9632 High Similarity NPC105283
0.9632 High Similarity NPC471457
0.9632 High Similarity NPC61791
0.9632 High Similarity NPC43587
0.9632 High Similarity NPC95855
0.9632 High Similarity NPC170675
0.9632 High Similarity NPC112755
0.963 High Similarity NPC70441
0.9581 High Similarity NPC241423
0.9581 High Similarity NPC473895
0.9581 High Similarity NPC473682
0.9581 High Similarity NPC473571
0.9581 High Similarity NPC470443
0.9581 High Similarity NPC126784
0.9581 High Similarity NPC470444
0.9581 High Similarity NPC110941
0.9578 High Similarity NPC169733
0.9573 High Similarity NPC210808
0.9573 High Similarity NPC105511
0.9573 High Similarity NPC34287
0.9573 High Similarity NPC474434
0.9573 High Similarity NPC471416
0.9573 High Similarity NPC199079
0.9527 High Similarity NPC148710
0.9521 High Similarity NPC472387
0.9518 High Similarity NPC198199
0.9515 High Similarity NPC205076
0.9515 High Similarity NPC9002
0.9515 High Similarity NPC137871
0.9515 High Similarity NPC257011
0.9515 High Similarity NPC48773
0.9515 High Similarity NPC307518
0.9515 High Similarity NPC288152
0.9515 High Similarity NPC180918
0.9512 High Similarity NPC186807
0.9512 High Similarity NPC183036
0.9512 High Similarity NPC93337
0.9512 High Similarity NPC195257
0.9512 High Similarity NPC226294
0.9512 High Similarity NPC469931
0.9512 High Similarity NPC86008
0.9512 High Similarity NPC45638
0.9512 High Similarity NPC201292
0.9512 High Similarity NPC58053
0.9512 High Similarity NPC209296
0.9512 High Similarity NPC105025
0.9512 High Similarity NPC475942
0.9512 High Similarity NPC229687
0.9509 High Similarity NPC236934
0.9509 High Similarity NPC5778
0.9467 High Similarity NPC470449
0.9467 High Similarity NPC470447
0.9467 High Similarity NPC470446
0.9467 High Similarity NPC470445
0.9467 High Similarity NPC473072
0.9461 High Similarity NPC8573
0.9461 High Similarity NPC472384
0.9461 High Similarity NPC48984
0.9461 High Similarity NPC65563
0.9461 High Similarity NPC472382
0.9461 High Similarity NPC470949
0.9461 High Similarity NPC472380
0.9461 High Similarity NPC255799
0.9458 High Similarity NPC208668
0.9455 High Similarity NPC224462
0.9455 High Similarity NPC51326
0.9455 High Similarity NPC231194
0.9451 High Similarity NPC45400
0.9451 High Similarity NPC146792
0.9451 High Similarity NPC45618
0.9451 High Similarity NPC135345
0.9451 High Similarity NPC58716
0.9448 High Similarity NPC475497
0.9448 High Similarity NPC15358
0.9448 High Similarity NPC284277
0.9448 High Similarity NPC475366
0.9412 High Similarity NPC470455
0.9412 High Similarity NPC470451
0.9408 High Similarity NPC473071
0.9408 High Similarity NPC473073
0.9405 High Similarity NPC476619
0.9405 High Similarity NPC89052
0.9405 High Similarity NPC476622
0.9405 High Similarity NPC476621
0.9405 High Similarity NPC476623
0.9405 High Similarity NPC120952
0.9405 High Similarity NPC476620
0.9405 High Similarity NPC476618
0.9405 High Similarity NPC251417
0.9401 High Similarity NPC294815
0.9401 High Similarity NPC16194
0.9401 High Similarity NPC476472
0.9401 High Similarity NPC473327
0.9401 High Similarity NPC19108
0.9401 High Similarity NPC220173
0.9398 High Similarity NPC172807
0.9398 High Similarity NPC261254
0.9398 High Similarity NPC256760
0.9398 High Similarity NPC254540
0.9398 High Similarity NPC476405
0.9398 High Similarity NPC211594
0.9398 High Similarity NPC117260
0.939 High Similarity NPC115674
0.939 High Similarity NPC210073
0.939 High Similarity NPC181616
0.939 High Similarity NPC8856
0.939 High Similarity NPC99957
0.9387 High Similarity NPC127415
0.9387 High Similarity NPC309025
0.9387 High Similarity NPC88023
0.9387 High Similarity NPC243930
0.9387 High Similarity NPC29830
0.936 High Similarity NPC473618
0.9353 High Similarity NPC473883
0.9349 High Similarity NPC192539
0.9345 High Similarity NPC219043
0.9345 High Similarity NPC14187
0.9345 High Similarity NPC268533
0.9345 High Similarity NPC202908
0.9345 High Similarity NPC122467
0.9345 High Similarity NPC292019
0.9345 High Similarity NPC257714
0.9341 High Similarity NPC21666
0.9341 High Similarity NPC169977
0.9341 High Similarity NPC45522
0.9341 High Similarity NPC25724
0.9341 High Similarity NPC24043
0.9341 High Similarity NPC42773
0.9341 High Similarity NPC101026
0.9337 High Similarity NPC285197
0.9337 High Similarity NPC150767
0.9337 High Similarity NPC218488
0.9337 High Similarity NPC78734
0.9337 High Similarity NPC245014
0.9337 High Similarity NPC84265
0.9337 High Similarity NPC282987
0.9337 High Similarity NPC67105
0.9333 High Similarity NPC477502
0.9333 High Similarity NPC229729
0.9329 High Similarity NPC311830
0.9329 High Similarity NPC165720
0.9329 High Similarity NPC22832
0.9325 High Similarity NPC148273
0.9325 High Similarity NPC300537
0.9325 High Similarity NPC127782
0.9321 High Similarity NPC97285
0.9321 High Similarity NPC142860
0.9321 High Similarity NPC271270
0.9321 High Similarity NPC246469
0.9302 High Similarity NPC179947
0.929 High Similarity NPC168584
0.929 High Similarity NPC173837
0.929 High Similarity NPC241196
0.9286 High Similarity NPC264735
0.9286 High Similarity NPC477848
0.9286 High Similarity NPC472607
0.9281 High Similarity NPC33054
0.9281 High Similarity NPC155877
0.9281 High Similarity NPC203259
0.9281 High Similarity NPC471748
0.9281 High Similarity NPC134532
0.9281 High Similarity NPC60735
0.9281 High Similarity NPC176740
0.9281 High Similarity NPC26230
0.9281 High Similarity NPC471725
0.9277 High Similarity NPC52382
0.9277 High Similarity NPC227508
0.9277 High Similarity NPC270578
0.9268 High Similarity NPC270335
0.9268 High Similarity NPC88043
0.9268 High Similarity NPC94777

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC102028 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9693 High Similarity NPD7074 Phase 3
0.9573 High Similarity NPD7472 Approved
0.9512 High Similarity NPD7054 Approved
0.9401 High Similarity NPD7808 Phase 3
0.9341 High Similarity NPD7251 Discontinued
0.9281 High Similarity NPD6797 Phase 2
0.9172 High Similarity NPD4338 Clinical (unspecified phase)
0.9102 High Similarity NPD3818 Discontinued
0.8982 High Similarity NPD6166 Phase 2
0.8982 High Similarity NPD6168 Clinical (unspecified phase)
0.8982 High Similarity NPD6167 Clinical (unspecified phase)
0.8963 High Similarity NPD4381 Clinical (unspecified phase)
0.8935 High Similarity NPD7804 Clinical (unspecified phase)
0.8834 High Similarity NPD1934 Approved
0.878 High Similarity NPD2801 Approved
0.8667 High Similarity NPD2393 Clinical (unspecified phase)
0.8521 High Similarity NPD5494 Approved
0.8452 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.84 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8393 Intermediate Similarity NPD3817 Phase 2
0.8373 Intermediate Similarity NPD4380 Phase 2
0.8352 Intermediate Similarity NPD6559 Discontinued
0.8343 Intermediate Similarity NPD3882 Suspended
0.8294 Intermediate Similarity NPD7075 Discontinued
0.8242 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8232 Intermediate Similarity NPD1511 Approved
0.8182 Intermediate Similarity NPD5844 Phase 1
0.8176 Intermediate Similarity NPD5402 Approved
0.8156 Intermediate Similarity NPD8313 Approved
0.8156 Intermediate Similarity NPD8312 Approved
0.8133 Intermediate Similarity NPD1512 Approved
0.8125 Intermediate Similarity NPD7228 Approved
0.8118 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8086 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8086 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.807 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8068 Intermediate Similarity NPD7473 Discontinued
0.8046 Intermediate Similarity NPD6959 Discontinued
0.8037 Intermediate Similarity NPD1549 Phase 2
0.8036 Intermediate Similarity NPD1653 Approved
0.8033 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD1465 Phase 2
0.8012 Intermediate Similarity NPD7819 Suspended
0.8 Intermediate Similarity NPD6232 Discontinued
0.7964 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7953 Intermediate Similarity NPD6801 Discontinued
0.7921 Intermediate Similarity NPD3751 Discontinued
0.7898 Intermediate Similarity NPD3787 Discontinued
0.7897 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7897 Intermediate Similarity NPD7783 Phase 2
0.7895 Intermediate Similarity NPD7411 Suspended
0.7887 Intermediate Similarity NPD8151 Discontinued
0.787 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7845 Intermediate Similarity NPD7685 Pre-registration
0.7845 Intermediate Similarity NPD7240 Approved
0.7842 Intermediate Similarity NPD6778 Approved
0.7842 Intermediate Similarity NPD6781 Approved
0.7842 Intermediate Similarity NPD6780 Approved
0.7842 Intermediate Similarity NPD6782 Approved
0.7842 Intermediate Similarity NPD6779 Approved
0.7842 Intermediate Similarity NPD6777 Approved
0.7842 Intermediate Similarity NPD6776 Approved
0.7841 Intermediate Similarity NPD7199 Phase 2
0.7812 Intermediate Similarity NPD7696 Phase 3
0.7812 Intermediate Similarity NPD7435 Discontinued
0.7812 Intermediate Similarity NPD7698 Approved
0.7812 Intermediate Similarity NPD7697 Approved
0.7805 Intermediate Similarity NPD2796 Approved
0.7803 Intermediate Similarity NPD8455 Phase 2
0.7798 Intermediate Similarity NPD6799 Approved
0.7772 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD5403 Approved
0.7751 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD37 Approved
0.7744 Intermediate Similarity NPD7701 Phase 2
0.7744 Intermediate Similarity NPD1510 Phase 2
0.7727 Intermediate Similarity NPD6234 Discontinued
0.7714 Intermediate Similarity NPD4966 Approved
0.7714 Intermediate Similarity NPD4967 Phase 2
0.7714 Intermediate Similarity NPD4965 Approved
0.7709 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.768 Intermediate Similarity NPD7870 Phase 2
0.768 Intermediate Similarity NPD7871 Phase 2
0.7668 Intermediate Similarity NPD6823 Phase 2
0.7654 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD7266 Discontinued
0.7647 Intermediate Similarity NPD5401 Approved
0.7644 Intermediate Similarity NPD7700 Phase 2
0.7644 Intermediate Similarity NPD7699 Phase 2
0.764 Intermediate Similarity NPD1247 Approved
0.763 Intermediate Similarity NPD6599 Discontinued
0.7607 Intermediate Similarity NPD1613 Approved
0.7607 Intermediate Similarity NPD1240 Approved
0.7607 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7602 Intermediate Similarity NPD7584 Approved
0.7588 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7579 Intermediate Similarity NPD6535 Approved
0.7579 Intermediate Similarity NPD6534 Approved
0.7576 Intermediate Similarity NPD7874 Approved
0.7576 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7556 Intermediate Similarity NPD3926 Phase 2
0.7538 Intermediate Similarity NPD7801 Approved
0.7515 Intermediate Similarity NPD1607 Approved
0.7515 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD7768 Phase 2
0.75 Intermediate Similarity NPD943 Approved
0.7485 Intermediate Similarity NPD2935 Discontinued
0.7472 Intermediate Similarity NPD3749 Approved
0.7455 Intermediate Similarity NPD1933 Approved
0.743 Intermediate Similarity NPD919 Approved
0.7423 Intermediate Similarity NPD3027 Phase 3
0.7412 Intermediate Similarity NPD4628 Phase 3
0.7412 Intermediate Similarity NPD3750 Approved
0.7411 Intermediate Similarity NPD8319 Approved
0.7411 Intermediate Similarity NPD8320 Phase 1
0.7396 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7385 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD6190 Approved
0.7362 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7354 Intermediate Similarity NPD8434 Phase 2
0.7354 Intermediate Similarity NPD8150 Discontinued
0.7349 Intermediate Similarity NPD230 Phase 1
0.7349 Intermediate Similarity NPD447 Suspended
0.7344 Intermediate Similarity NPD6212 Phase 3
0.7344 Intermediate Similarity NPD6213 Phase 3
0.7344 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7341 Intermediate Similarity NPD2534 Approved
0.7341 Intermediate Similarity NPD2532 Approved
0.7341 Intermediate Similarity NPD2533 Approved
0.7333 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD1551 Phase 2
0.7273 Intermediate Similarity NPD7680 Approved
0.7273 Intermediate Similarity NPD7458 Discontinued
0.7251 Intermediate Similarity NPD2800 Approved
0.7251 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD6674 Discontinued
0.7247 Intermediate Similarity NPD6844 Discontinued
0.7231 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD5953 Discontinued
0.7214 Intermediate Similarity NPD7585 Approved
0.7212 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7204 Intermediate Similarity NPD7286 Phase 2
0.7176 Intermediate Similarity NPD6100 Approved
0.7176 Intermediate Similarity NPD6099 Approved
0.7175 Intermediate Similarity NPD3226 Approved
0.7164 Intermediate Similarity NPD7583 Approved
0.7159 Intermediate Similarity NPD920 Approved
0.7143 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD3748 Approved
0.7101 Intermediate Similarity NPD6651 Approved
0.7086 Intermediate Similarity NPD7390 Discontinued
0.7072 Intermediate Similarity NPD5353 Approved
0.7053 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD6832 Phase 2
0.7048 Intermediate Similarity NPD4908 Phase 1
0.7045 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7042 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7042 Intermediate Similarity NPD8059 Phase 3
0.7041 Intermediate Similarity NPD4360 Phase 2
0.7041 Intermediate Similarity NPD4363 Phase 3
0.7037 Intermediate Similarity NPD1091 Approved
0.7035 Intermediate Similarity NPD2346 Discontinued
0.7035 Intermediate Similarity NPD2344 Approved
0.703 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD2799 Discontinued
0.7018 Intermediate Similarity NPD7033 Discontinued
0.7018 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.6989 Remote Similarity NPD5242 Approved
0.6988 Remote Similarity NPD9494 Approved
0.6981 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6973 Remote Similarity NPD8127 Discontinued
0.6965 Remote Similarity NPD5005 Approved
0.6965 Remote Similarity NPD5006 Approved
0.6964 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6964 Remote Similarity NPD2313 Discontinued
0.6963 Remote Similarity NPD7549 Discontinued
0.6959 Remote Similarity NPD6843 Phase 3
0.6959 Remote Similarity NPD6842 Approved
0.6959 Remote Similarity NPD7097 Phase 1
0.6959 Remote Similarity NPD6841 Approved
0.6954 Remote Similarity NPD1243 Approved
0.6935 Remote Similarity NPD5710 Approved
0.6935 Remote Similarity NPD5711 Approved
0.6933 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6932 Remote Similarity NPD643 Clinical (unspecified phase)
0.6928 Remote Similarity NPD2798 Approved
0.6923 Remote Similarity NPD6233 Phase 2
0.6923 Remote Similarity NPD7930 Approved
0.6919 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6906 Remote Similarity NPD6385 Approved
0.6906 Remote Similarity NPD6386 Approved
0.6891 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6889 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6886 Remote Similarity NPD2861 Phase 2
0.6875 Remote Similarity NPD2309 Approved
0.6867 Remote Similarity NPD1203 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data